Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study

References

• Chandra A, Pius C, Nabeel M, et al. Ovarian cancer: current status and strategies for improving therapeutic outcomes. Cancer Med. 2019;8(16):7018–7031. doi:10.1002/cam4.256031560828
   PubMed Web of Science ®Google Scholar
• Stenzel AE, Buas MF, Moysich KB. Survival disparities among racial/ethnic groups of women with ovarian cancer: an update on data from the Surveillance, Epidemiology and End Results (SEER) registry. Cancer Epidemiol. 2019;62:101580. doi:10.1016/j.canep.2019.10158031400533
   PubMed Web of Science ®Google Scholar
• Liu CH, Horng HC, Wang PH. A case of ovarian cancer present with acute respiratory distress: spontaneous rupture of diaphragm. Taiwan J Obstet Gynecol. 2019;58(5):712–714. doi:10.1016/j.tjog.2019.07.02431542099
   PubMed Web of Science ®Google Scholar
• Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240–1253. doi:10.1016/S0140-6736(18)32552-230910306
   PubMed Web of Science ®Google Scholar
• Vergote I, Coens C, Nankivell M, et al. EORTC; MRC CHORUS study investigators. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials. Lancet Oncol. 2018;19(12):1680–1687. doi:10.1016/S1470-2045(18)30566-730413383
   PubMed Web of Science ®Google Scholar
• González-Martín A, Pothuri B, Vergote I, et al. PRIMA/ENGOT-OV26/GOG-3012 Investigators. Niraparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med. 2019. doi:10.1056/NEJMoa1910962
   Web of Science ®Google Scholar
• Coleman RL, Fleming GF, Brady MF, et al. Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer. N Engl J Med. 2019;381(25):2403–2415. doi:10.1056/NEJMoa190970731562800
   PubMed Web of Science ®Google Scholar
• Mateo J, Lord CJ, Serra V, et al. A decade of clinical development of PARP inhibitors in perspective. Ann Oncol. 2019;30(9):1437–1447. doi:10.1093/annonc/mdz19231218365
   PubMed Web of Science ®Google Scholar
• Naumann RW, Coleman RL, Brown J, Moore KN. Phase III trials in ovarian cancer: the evolving landscape of front line therapy. Gynecol Oncol. 2019;153(2):436–444. doi:10.1016/j.ygyno.2019.02.00830765149
   PubMed Web of Science ®Google Scholar
• Chikazawa K, Netsu S, Kuwata T, Konno R. Bevacizumab improves overall survival in platinum refractory ovarian cancer patients: A retrospective study. Taiwan J Obstet Gynecol. 2018;57(6):819–824. doi:10.1016/j.tjog.2018.10.0030545534
   PubMed Web of Science ®Google Scholar
• Wang PH. Neoadjuvant chemotherapy before definite operative approach for women with advanced-stage epithelial ovarian cancer. Taiwan J Obstet Gynecol. 2018;57(5):623–624. doi:10.1016/j.tjog.2018.08.00130342639
   PubMed Web of Science ®Google Scholar
• Dixon-Suen SC, Webb PM, Wilson LF, Tuesley K, Stewart LM, Jordan SJ. The Association between hysterectomy and ovarian cancer risk: A population-based record-linkage study. J Natl Cancer Inst. 2019;111(10):1097–1103. doi:10.1093/jnci/djz01530753695
   PubMedGoogle Scholar
• Vassard D, Schmidt L, Glazer CH, Lyng Forman J, Kamper-Jørgensen M, Pinborg A. Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study. Hum Reprod. 2019;34(11):2290–2296.pii: dez165. doi:10.1093/humrep/dez165
   Web of Science ®Google Scholar
• Stentz NC, Koelper N, Barnhart KT, Sammel MD, Senapati S. Infertility and Mortality. Am J Obstet Gynecol. 2019;pii: S0002–9378(19):31112–31113. doi:10.1016/j.ajog.2019.09.007
   Web of Science ®Google Scholar
• Cristiano S, Leal A, Phallen J, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. 2019;570(7761):385–389. doi:10.1038/s41586-019-1272-631142840
   PubMed Web of Science ®Google Scholar
• Sundbøll J, Thygesen SK, Veres K, et al. Risk of cancer in patients with constipation. Clin Epidemiol. 2019;11:299–310. doi:10.2147/CLEP.S20595731118818
   PubMed Web of Science ®Google Scholar
• van Lieshout LAM, Steenbeek MP, De Hullu JA, et al. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone. Cochrane Database Syst Rev. 2019;8:CD012858. doi:10.1002/14651858.CD012858.pub231456223
   PubMed Web of Science ®Google Scholar
• Wheeler LJ, Desanto K, Teal SB, Sheeder J, Guntupalli SR. Intrauterine device use and ovarian cancer risk: a systematic review and meta-analysis. Obstet Gynecol. 2019;134(4):791–800. doi:10.1097/AOG.000000000000346331503144
   PubMed Web of Science ®Google Scholar
• Nelson HD, Pappas M, Cantor A, Haney E, Holmes R. Risk assessment, genetic counseling, and genetic testing for brca-related cancer in women. JAMA. 2019;322(7):666–685. doi:10.1001/jama.2019.843031429902
   PubMed Web of Science ®Google Scholar
• Yarmolinsky J, Relton CL, Lophatananon A, et al. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: a Mendelian randomization analysis. PLoS Med. 2019;16(8):e1002893. doi:10.1371/journal.pmed.100289331390370
   PubMed Web of Science ®Google Scholar
• Owens DK, Davidson KW, Krist AH, et al.; US Preventive Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer. JAMA. 2019;322(7):652–665. doi:10.1001/jama.2019.1098731429903
   PubMed Web of Science ®Google Scholar
• Zheng G, Chattopadhyay S, Försti A, Sundquist K, Hemminki K. Familial risks of second primary cancers and mortality in ovarian cancer patients. Clin Epidemiol. 2018;10:1457–1466. doi:10.2147/CLEP.S17417330349393
   PubMed Web of Science ®Google Scholar
• Mallen A, Soong TR, Townsend MK, Wenham RM, Crum CP, Tworoger SS. Surgical prevention strategies in ovarian cancer. Gynecol Oncol. 2018;151(1):166–175. doi:10.1016/j.ygyno.2018.08.00530087058
   PubMed Web of Science ®Google Scholar
• Koushik A, Grundy A, Abrahamowicz M, et al. Hormonal and reproductive factors and the risk of ovarian cancer. Cancer Causes Control. 2017;28(5):393–403. doi:10.1007/s10552-016-0848-928102526
   PubMed Web of Science ®Google Scholar
• Lee WL, Chang WH, Wang KC, et al. The risk of epithelial ovarian cancer of women with endometriosis may be varied greatly if diagnostic criteria are different: a nationwide population-based cohort study. Medicine (Baltimore). 2015;94(39):e1633. doi:10.1097/MD.000000000000163326426652
   PubMed Web of Science ®Google Scholar
• Murakami K, Kotani Y, Shiro R, Takaya H, Nakai H, Matsumura N. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts. Int J Clin Oncol. 2020;25(1):51–58. doi:10.1007/s10147-019-01536-531473885
   PubMed Web of Science ®Google Scholar
• Su KM, Wang PH, Yu MH, Chang CM, Chang CC. The recent progress and therapy in endometriosis-associated ovarian cancer. J Chin Med Assoc. 2020;83(3):227–232. doi:10.1097/JCMA.000000000000026231985569
   PubMed Web of Science ®Google Scholar
• Hsu HC, Tseng KY, Wang HC, Sung FC, Ma WF. Risk of endometriosis and subsequent ovary and breast cancers in nurses: a population-based cohort study in Taiwan. Int J Environ Res Public Health. 2019;16(18):3469. doi:10.3390/ijerph16183469
   Web of Science ®Google Scholar
• Sapalidis K, Machairiotis N, Zarogoulidis P, et al. Genes’ interactions: a major contributor to the malignant transformation of endometriosis. Int J Mol Sci. 2019;20(8):1842. doi:10.3390/ijms20081842
   Web of Science ®Google Scholar
• Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–1079. doi:10.1210/er.2018-0024230994890
   PubMed Web of Science ®Google Scholar
• Bulun SE, Wan Y, Matei D. Epithelial mutations in endometriosis: link to ovarian cancer. Endocrinology. 2019;160(3):626–638. doi:10.1210/en.2018-0079430657901
   PubMed Web of Science ®Google Scholar
• Kajiyama H, Suzuki S, Yoshihara M, et al. Endometriosis and cancer. Free Radic Biol Med. 2019;133:186–192. doi:10.1016/j.freeradbiomed.2018.12.01530562557
   PubMed Web of Science ®Google Scholar
• Lee WL, Wang PH. Aberrant sialylation in ovarian cancers. J Chin Med Assoc. 2020;83(4):337-344. doi:10.1097/JCMA.0000000000000252.
   Web of Science ®Google Scholar
• Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol. 2017;209:3–7. doi:10.1016/j.ejogrb.2016.04.02127216973
   PubMed Web of Science ®Google Scholar
• Teng SW, Horng HC, Ho CH, Yen MS, Chao HT, Wang PH. Taiwan association of gynecology systematic review group. women with endometriosis have higher comorbidities: analysis of domestic data in Taiwan. J Chin Med Assoc. 2016;79(11):577–582. doi:10.1016/j.jcma.2016.04.00627553580
   PubMed Web of Science ®Google Scholar
• Li J, Liu R, Tang S, et al. Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis. Arch Gynecol Obstet. 2019;299(1):35–46. doi:10.1007/s00404-018-4968-130460611
   PubMed Web of Science ®Google Scholar
• Poole EM, Lin WT, Kvaskoff M, De Vivo I, Terry KL, Missmer SA. Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses. Cancer Causes Control. 2017;28(5):437–445. doi:10.1007/s10552-017-0856-428299512
   PubMed Web of Science ®Google Scholar
• Guo SW. Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery. Fertil Steril. 2015;104(4):813–830. doi:10.1016/j.fertnstert.2015.08.00626335131
   PubMed Web of Science ®Google Scholar
• Burghaus S, Häberle L, Schrauder MG, et al. Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study. BMC Cancer. 2015;15(1):751. doi:10.1186/s12885-015-1821-926487094
   PubMed Web of Science ®Google Scholar
• Chang WH, Wang KC, Lee WL, et al. Endometriosis and the subsequent risk of epithelial ovarian cancer. Taiwan J Obstet Gynecol. 2014;53(4):530–535. doi:10.1016/j.tjog.2014.04.02525510696
   PubMed Web of Science ®Google Scholar
• Wang KC, Chang WH, Lee WL, et al. An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis. BMC Cancer. 2014;14(1):831. doi:10.1186/1471-2407-14-83125403543
   PubMed Web of Science ®Google Scholar
• Buis CC, van Leeuwen FE, Mooij TM, Burger CW, OMEGA Project Group. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod. 2013;28(12):3358–3369. doi:10.1093/humrep/det34024014607
   PubMed Web of Science ®Google Scholar
• Melin AS, Lundholm C, Malki N, Swahn ML, Sparèn P, Bergqvist A. Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer. Acta Obstet Gynecol Scand. 2013;92(5):546–554. doi:10.1111/aogs.1212323560387
   PubMed Web of Science ®Google Scholar
• Pearce CL, Templeman C, Rossing MA, et al. Ovarian cancer association consortium. association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol. 2012;13(4):385–394. doi:10.1016/S1470-2045(11)70404-122361336
   PubMed Web of Science ®Google Scholar
• Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA. Postmenopausal cancer risk after self-reported endometriosis diagnosis in the iowa women’s health study. Cancer. 2002;94(5):1612–1618. doi:10.1002/cncr.1037011920519
   PubMed Web of Science ®Google Scholar
• Lai KM, Chen TL, Chang CC, Chen HH, Lee YW. Association between NSAID use and mortality risk in patients with end-stage renal disease: a population-based cohort study. Clin Epidemiol. 2019;11:429–441. doi:10.2147/CLEP.S20432231213924
   PubMed Web of Science ®Google Scholar
• Harnod T, Lin CL, Kao CH. Epilepsy is associated with higher subsequent mortality risk in patients after stroke: a population-based cohort study in Taiwan. Clin Epidemiol. 2019;11:247–255. doi:10.2147/CLEP.S20126331114385
   PubMed Web of Science ®Google Scholar
• Chan IC, Lee YS, Chuang CM, Soong WJ. The influence of pleurodesis on the outcome of primary spontaneous pneumothorax in children. J Chin Med Assoc. 2019;82(4):305–311. doi:10.1097/JCMA.000000000000007330865105
   PubMed Web of Science ®Google Scholar
• Li JY, Wang PH, Vitale SG, et al. Pregnancy-induced hypertension is an independent risk factor for meconium aspiration syndrome: a retrospective population based cohort study. Taiwan J Obstet Gynecol. 2019;58(3):396–400. doi:10.1016/j.tjog.2018.11.03431122532
   PubMed Web of Science ®Google Scholar
• Chen SN, Wang PH, Hsieh MF, Tsai HW, Lin LT, Tsui KH. Maternal pregnancy-induced hypertension increases the subsequent risk of neonatal candidiasis: a nationwide population-based cohort study. Taiwan J Obstet Gynecol. 2019;58(2):261–265. doi:10.1016/j.tjog.2019.01.01730910150
   PubMed Web of Science ®Google Scholar
• Kreiger N, Sloan M, Cotterchio M, Parsons P. Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol. 1997;26(4):710–715. doi:10.1093/ije/26.4.7109279601
   PubMed Web of Science ®Google Scholar
• Chiaffarino F, Parazzini F, Decarli A, et al. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer. Gynecol Oncol. 2005;97(2):318–322. doi:10.1016/j.ygyno.2005.01.03015863124
   PubMed Web of Science ®Google Scholar
• Annegers JF, Strom H, Decker DG, Dockerty MB, O’Fallon WM. Ovarian cancer: incidence and case-control study. Cancer. 1979;43(2):723–729. doi:10.1002/1097-0142(197902)43:2<723::aid-cncr2820430248>3.0.co;2-1421190
   PubMed Web of Science ®Google Scholar
• Beard CM, Hartmann LC, Atkinson EJ, et al. The epidemiology of ovarian cancer: a population-based study in Olmsted County, Minnesota, 1935–1991. Ann Epidemiol. 2000;10(1):14–23. doi:10.1016/s1047-2797(99)00045-910658685
   PubMed Web of Science ®Google Scholar
• Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control. 2008;19(10):1357–1364. doi:10.1007/s10552-008-9207-918704718
   PubMed Web of Science ®Google Scholar
• Haraguchi H, Koga K, Takamura M, et al. Development of ovarian cancer after excision of endometrioma. Fertil Steril. 2016;106(6):1432–1437.e2. doi:10.1016/j.fertnstert.2016.07.107727543889
   PubMed Web of Science ®Google Scholar
• Chan CH, Yang SF, Yeh HW, et al. Risk of pneumonia in patients with burn injury: a population-based cohort study. Clin Epidemiol. 2018;10:1083–1091. doi:10.2147/CLEP.S17298030214313
   PubMed Web of Science ®Google Scholar
• Chi NF, Kuan YC, Huang YH, et al. Development and validation of risk score to estimate 1-year late poststroke epilepsy risk in ischemic stroke patients. Clin Epidemiol. 2018;10:1001–1011. doi:10.2147/CLEP.S16816930174459
   PubMed Web of Science ®Google Scholar
• Liu FC, Lin HT, Kuo CF, Hsieh MY, See LC, Yu HP. Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study. Clin Epidemiol. 2018;10:631–641. doi:10.2147/CLEP.S16433029881310
   PubMed Web of Science ®Google Scholar
• Chang WS, Lin LT, Hsu LC, Tang PL, Tsui KH, Wang PH. Maternal pregnancy-induced hypertension increases the subsequent risk of transient tachypnea of the newborn: a nationwide population-based cohort study. Taiwan J Obstet Gynecol. 2018;57(4):546–550. doi:10.1016/j.tjog.2018.06.01330122576
   PubMed Web of Science ®Google Scholar
• Liao HT, Lin MC, Tsai CY, Hsu CY, Wu TH. Renal transplantation delays major adverse cardiac events (MACEs) in patients with end-stage renal disease: a nationwide population-based study. J Chin Med Assoc. 2018;81(9):766–771. doi:10.1016/j.jcma.2018.04.00330173723
   PubMed Web of Science ®Google Scholar
• Lin TK, Liou YS, Lin CH, Chou P, Jong GP. High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study. Clin Epidemiol. 2018;10:159–165. doi:10.2147/CLEP.S14531129403315
   PubMed Web of Science ®Google Scholar
• Huang BS, Chang WH, Wang KC, et al. Endometriosis might be inversely associated with developing chronic kidney disease: a population-based cohort study in Taiwan. Int J Mol Sci. 2016;17(7):1079. doi:10.3390/ijms17071079
   Web of Science ®Google Scholar
• Tavassoeli FA. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC press; 2003.
   Google Scholar
• Chiang YC, Chen CA, Chiang CJ, et al. Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan. J Gynecol Oncol. 2013;24(4):342–351. doi:10.3802/jgo.2013.24.4.34224167670
   PubMed Web of Science ®Google Scholar
• Tseng JJ, Huang CC, Chiang HY, Chen YH, Lin CH. Prior uterine myoma and risk of ovarian cancer: a population-based case-control study. J Gynecol Oncol. 2019;30(5):e72. doi:10.3802/jgo.2019.30.e7231328455
   PubMed Web of Science ®Google Scholar
• Ding DC, Chen W, Wang JH, Lin SZ. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: a population-based cohort study in Taiwan. Medicine (Baltimore). 2018;97(39):e12608. doi:10.1097/MD.000000000001260830278576
   PubMed Web of Science ®Google Scholar
• Chang LC, Huang CF, Lai MS, Shen LJ, Wu FL, Cheng WF. Prognostic factors in epithelial ovarian cancer: a population-based study. PLoS One. 2018;13(3):e0194993. doi:10.1371/journal.pone.019499329579127
   PubMed Web of Science ®Google Scholar
• Kamiza AB, Su FH, Wang WC, Sung FC, Chang SN, Yeh CC. Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan. BMC Cancer. 2016;16(1):861. doi:10.1186/s12885-016-2918-527821099
   PubMed Web of Science ®Google Scholar
• Shen CC, Hu LY, Yang AC, Chiang YY, Hung JH, Tsai SJ. Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study. BMC Cancer. 2016;16(1):839. doi:10.1186/s12885-016-2857-127809870
   PubMed Web of Science ®Google Scholar
• Kok VC, Tsai HJ, Su CF, Lee CK. The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study. Int J Gynecol Cancer. 2015;25(6):968–976. doi:10.1097/IGC.000000000000045425893280
   PubMed Web of Science ®Google Scholar
• Yu HC, Lin CY, Chang WC, Shen BJ, Chang WP, Chuang CM. Task force on carcinogenesis of endometrial cancer. increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study. Int J Gynecol Cancer. 2015;25(3):447–452. doi:10.1097/IGC.000000000000038425695548
   PubMed Web of Science ®Google Scholar
• Shen CC, Yang AC, Hung JH, Hu LY, Tsai SJ. A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome. Oncologist. 2015;20(1):45–49. doi:10.1634/theoncologist.2014-031125410097
   PubMed Web of Science ®Google Scholar
• Hsu PC, Lin WH, Kuo TH, Lee HM, Kuo C, Li CY. A population-based cohort study of all-cause and site-specific cancer incidence among patients with type 1 diabetes mellitus in Taiwan. J Epidemiol. 2015;25(9):567–573. doi:10.2188/jea.JE2014019726212724
   PubMed Web of Science ®Google Scholar
• Chen HF, Chang YH, Ko MC, Li CY. A large scale population-based cohort study on the risk of ovarian neoplasm in patients with type 2 diabetes mellitus. Gynecol Oncol. 2014;134(3):576–580. doi:10.1016/j.ygyno.2014.07.00125014539
   PubMed Web of Science ®Google Scholar
• Wu MP, Wu CJ, Long CY, et al. Surgical trends for benign ovarian tumors among hospitals of different accreditation levels: an 11-year nationwide population-based descriptive study in Taiwan. Taiwan J Obstet Gynecol. 2013;52(4):498–504. doi:10.1016/j.tjog.2013.10.00824411033
   PubMed Web of Science ®Google Scholar
• Lin HW, Tu YY, Lin SY, et al. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol. 2011;12(9):900–904. doi:10.1016/S1470-2045(11)70165-621835693
   PubMed Web of Science ®Google Scholar
• Shih CY, Lai CR, Huang CY, Twu NF, Chao KC, Wang PH. A challenge in the management of a patient with ovarian cancer associated with extensive endometriosis. Taiwan J Obstet Gynecol. 2012;51(2):324–325. doi:10.1016/j.tjog.2012.04.03522795124
   PubMed Web of Science ®Google Scholar
• Evans EC, Matteson KA, Orejuela FJ, et al. Society of gynecologic surgeons systematic review group. salpingo-oophorectomy at the time of benign hysterectomy: a systematic review. Obstet Gynecol. 2016;128(3):476–485. doi:10.1097/AOG.000000000000159227500347
   PubMed Web of Science ®Google Scholar
• Wentzensen N, Poole EM, Trabert B, et al. Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium. J Clin Oncol. 2016;34(24):2888–2898. doi:10.1200/JCO.2016.66.817827325851
   PubMed Web of Science ®Google Scholar
• Wang C, Liang Z, Liu X, Zhang Q, Li S. The association between endometriosis, tubal ligation, hysterectomy and epithelial ovarian cancer: meta-analyses. Int J Environ Res Public Health. 2016;13(11):1138. doi:10.3390/ijerph13111138
   Web of Science ®Google Scholar
• Zhang Y, Qu P. Factors associated with ovarian endometriosis malignancy and its recurrence in Chinese women. J Obstet Gynaecol. 2019;39(8):1148–1153. doi:10.1080/01443615.2019.160320931307261
   PubMedGoogle Scholar
• Saraswat L, Ayansina D, Cooper KG, Bhattacharya S, Horne AW, Bhattacharya S. Impact of endometriosis on risk of further gynaecological surgery and cancer: a national cohort study. BJOG. 2018;125(1):64–72. doi:10.1111/1471-0528.1479328952173
   PubMed Web of Science ®Google Scholar
• Matthews CA. Management strategies for the ovaries at the time of hysterectomy for benign disease. Obstet Gynecol Clin North Am. 2016;43(3):539–549. doi:10.1016/j.ogc.2016.04.01127521883
   PubMed Web of Science ®Google Scholar
• Mikhail E, Salemi JL, Mogos MF, Hart S, Salihu HM, Imudia AN. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998–2011. Am J Obstet Gynecol. 2015;213(5):713.e1-13. doi:10.1016/j.ajog.2015.04.031
   Web of Science ®Google Scholar
• Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses’ Health Studies. Fertil Steril. 2014;102(1):192–198.e3. doi:10.1016/j.fertnstert.2014.03.04124825424
   PubMed Web of Science ®Google Scholar
• Orozco LJ, Tristan M, Vreugdenhil MM, Salazar A. Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women. Cochrane Database Syst Rev. 2014;7:CD005638. doi:10.1002/14651858.CD005638.pub3
   Web of Science ®Google Scholar
• Gaudet MM, Gapstur SM, Sun J, Teras LR, Campbell PT, Patel AV. Oophorectomy and hysterectomy and cancer incidence in the cancer prevention study-ii nutrition cohort. Obstet Gynecol. 2014;123(6):1247–1255. doi:10.1097/AOG.000000000000027024807324
   PubMed Web of Science ®Google Scholar
• Obermair A, Youlden DR, Baade PD, Janda M. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer–a population-based data linkage study. Int J Cancer. 2014;134(9):2211–2222. doi:10.1002/ijc.2853724127248
   PubMed Web of Science ®Google Scholar
• McAlpine JN, Hanley GE, Woo MM, et al. Ovarian Cancer research program of british columbia. opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. Am J Obstet Gynecol. 2014;210(5):471.e1-11. doi:10.1016/j.ajog.2014.01.003
   Web of Science ®Google Scholar
• Vorwergk J, Radosa MP, Nicolaus K, et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate. J Cancer Res Clin Oncol. 2014;140(5):859–865. doi:10.1007/s00432-014-1622-624573653
   PubMed Web of Science ®Google Scholar
• Harmanli O, Shinnick J, Jones K, St Marie P. Obstetrician-gynecologists’ opinions on elective bilateral oophorectomy at the time of hysterectomy in the United States: a nationwide survey. Menopause. 2014;21(4):355–360. doi:10.1097/GME.0b013e31829fc37623942250
   PubMed Web of Science ®Google Scholar
• Boggs DA, Palmer JR, Rosenberg L. Bilateral oophorectomy and risk of cancer in African American women. Cancer Causes Control. 2014;25(4):507–713. doi:10.1007/s10552-014-0353-y24487726
   PubMed Web of Science ®Google Scholar
• Larson CA. Prophylactic bilateral oophorectomy at time of hysterectomy for women at low risk: ACOG revises practice guidelines for ovarian cancer screening in low-risk women. Curr Oncol. 2014;21(1):9–12. doi:10.3747/co.21.172124523599
   PubMed Web of Science ®Google Scholar
• Jordan SJ, Nagle CM, Coory MD, et al. Has the association between hysterectomy and ovarian cancer changed over time? A systematic review and meta-analysis. Eur J Cancer. 2013;49(17):3638–3647. doi:10.1016/j.ejca.2013.07.00523890943
   PubMed Web of Science ®Google Scholar
• Rice MS, Murphy MA, Tworoger SS. Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis. J Ovarian Res. 2012;5(1):13. doi:10.1186/1757-2215-5-1322587442
   PubMed Web of Science ®Google Scholar
• Rice MS, Murphy MA, Vitonis AF, et al. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study. Int J Cancer. 2013;133(10):2415–2421. doi:10.1002/ijc.2824923650079
   PubMed Web of Science ®Google Scholar
• Salazar C, Campbell IG, Gorringe KL. When is “type I” ovarian cancer not “type I”? Indications of an out-dated dichotomy. Front Oncol. 2018;8:654. doi:10.3389/fonc.2018.0065430627526
   PubMed Web of Science ®Google Scholar
• Cybulska P, Paula ADC, Tseng J, et al. Molecular profiling and molecular classification of endometrioid ovarian carcinomas. Gynecol Oncol. 2019;154(3):516–523. doi:10.1016/j.ygyno.2019.07.01231340883
   PubMed Web of Science ®Google Scholar
• Mueller JJ, Schlappe BA, Kumar R, et al. Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses. Gynecol Oncol. 2018;150(1):127–135. doi:10.1016/j.ygyno.2018.05.00829793804
   PubMed Web of Science ®Google Scholar
• Prat J, D’Angelo E, Espinosa I. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics. Hum Pathol. 2018;80:11–27. doi:10.1016/j.humpath.2018.06.01829944973
   PubMed Web of Science ®Google Scholar
• Imai A, Matsunami K, Takagi H, Ichigo S. Malignant neoplasia arising from ovarian remnants following bilateral salpingo-oophorectomy (Review). Oncol Lett. 2014;8(1):3–6. doi:10.3892/ol.2014.208924959210
   PubMed Web of Science ®Google Scholar
• Lai CR, Yen MS, Wang PH. Neoplasms in the trocar site and peritoneal papillary serous cystadenocarcinoma. Taiwan J Obstet Gynecol. 2014;53(2):139–140. doi:10.1016/j.tjog.2014.04.00225017255
   PubMed Web of Science ®Google Scholar
• Kho RM, Abrao MS. Ovarian remnant syndrome: etiology, diagnosis, treatment and impact of endometriosis. Curr Opin Obstet Gynecol. 2012;24(4):210–214. doi:10.1097/GCO.0b013e328355853922729094
   PubMed Web of Science ®Google Scholar
• Donnez O, Squifflet J, Marbaix E, Jadoul P, Donnez J. Primary ovarian adenocarcinoma developing in ovarian remnant tissue ten years after laparoscopic hysterectomy and bilateral salpingo-oophorectomy for endometriosis. J Minim Invasive Gynecol. 2007;14(6):752–757. doi:10.1016/j.jmig.2007.05.00517980339
   PubMed Web of Science ®Google Scholar
• Bannay A, Chaignot C, Blotière PO, et al. The best use of the Charlson comorbidity index with electronic health care database to predict mortality. Med Care. 2016;54(2):188–194. doi:10.1097/MLR.000000000000047126683778
   PubMed Web of Science ®Google Scholar
• Pylväläinen J, Talala K, Murtola T, et al. Charlson comorbidity index based on hospital episode statistics performs adequately in predicting mortality, but its discriminative ability diminishes over time. Clin Epidemiol. 2019;11:923–932. doi:10.2147/CLEP.S21869731695505
   PubMed Web of Science ®Google Scholar
• Schelde AB, Schmidt M, Madsen M, Nielsen SS, Frøkiær J, Christiansen CF. Impact of the Charlson Comorbidity Index score on risk prediction by single-photon emission computed tomography myocardial perfusion imaging following myocardial infarction. Clin Epidemiol. 2019;11:901–910. doi:10.2147/CLEP.S21155531576177
   PubMed Web of Science ®Google Scholar
• Glassou EN, Kjørholt KK, Hansen TB, Pedersen AB. Delay in surgery, risk of hospital-treated infections and the prognostic impact of comorbidity in hip fracture patients. A Danish nationwide cohort study, 2005–2016. Clin Epidemiol. 2019;11:383–395. doi:10.2147/CLEP.S20045431191031
   PubMed Web of Science ®Google Scholar
• Arostegui I, Gonzalez N, Fernández-de-Larrea N, et al., REDISSEC CARESS-CCR Group. Combining statistical techniques to predict postsurgical risk of 1-year mortality for patients with colon cancer. Clin Epidemiol. 2018;10:235–251. doi:10.2147/CLEP.S14672929563837
   PubMed Web of Science ®Google Scholar
• Krassuski L, Vennedey V, Stock S, Kautz-Freimuth S. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review. BMC Med Inform Decis Mak. 2019;19(1):154. doi:10.1186/s12911-019-0872-231370837
   PubMed Web of Science ®Google Scholar
• Nené NR, Reisel D, Leimbach A, et al. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. Lancet Oncol. 2019;20(8):1171–1182. doi:10.1016/S1470-2045(19)30340-731300207
   PubMed Web of Science ®Google Scholar
• Huang T, Townsend MK, Wentzensen N, et al. Reproductive and hormonal factors and risk of ovarian cancer by tumor dominance: results from the Ovarian Cancer Cohort Consortium (OC3). Cancer Epidemiol Biomarkers Prev. 2019;2019:pii: cebp.0734. doi:10.1158/1055-9965.EPI-19-0734
   Web of Science ®Google Scholar
• Trabert B, Michels KA, Anderson GL, et al. Circulating androgens and postmenopausal ovarian cancer risk in the Women’s Health Initiative Observational Study. Int J Cancer. 2019;145(8):2051–2060. doi:10.1002/ijc.3215730684389
   PubMed Web of Science ®Google Scholar
• Gasparri ML, Taghavi K, Fiacco E, et al. Risk-reducing bilateral salpingo-oophorectomy for BRCA mutation carriers and hormonal replacement therapy: if it should rain, better a drizzle than a storm. Medicina (Kaunas). 2019;55(8):415. doi:10.3390/medicina55080415
   Web of Science ®Google Scholar
• Cheng M, Lee HH, Chang WH, et al. Weekly dose-dense paclitaxel and tri-weekly low dose cisplatin: A well-tolerated and effective chemotherapeutic regimen for first-line treatment of advanced ovarian, fallopian tube, and primary peritoneal cancer. Int J Environ Res Public Health. 2019;16(23):4794. doi:10.3390/ijerph16234794
   Web of Science ®Google Scholar